Target intelligence / Profile preview

MicroRNA 4742 (MIR4742)

Target
MIR4742
Molecular classification
microRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 4742 is a human microRNA belonging to the non-coding RNA family, primarily involved in post-transcriptional regulation of gene expression. Like other microRNAs, it acts as a repressor by binding to complementary sequences within the 3′ untranslated region (UTR) of target mRNAs, leading to mRNA degradation or translational inhibition. MicroRNAs are present in plants, animals, and viruses, and collectively modulate a substantial fraction of protein-coding genes. MIR4742 has not been specifically linked to any individual disease or clinical drug targeting in current literature, but microRNAs broadly are involved in pathological and physiological processes and are recognized as potential biomarkers and therapeutic targets[1][2][3].\n\nIf more direct functional, disease, or drug interaction data specific to MIR4742 emerges, these annotations can be updated accordingly. As of now, information is based on its molecular classification and generalized knowledge about microRNAs.

Other names
hsa-mir-4742mir-4742MIR4742
02

Mechanism of action

Drugs targeting microRNAs typically work by RNA interference or antisense inhibition, suppressing the microRNA's ability to bind mRNA and regulate gene expression post-transcriptionally

03

Biological functions

Post-transcriptional gene silencingNegative regulation of gene expressionRNA interference
04

Disease associations

Other (microRNAs are frequently implicated in various diseases; specific disease associations for MIR4742 were not found in the current results. MicroRNAs in general can act as oncogenes, tumor suppressors, and modulators in cardiovascular, neurodegenerative, and immune diseases)
05

Safety considerations

Off-target effects and broad gene regulation are major concerns when targeting microRNAs for therapy. Modulation might disrupt normal gene regulatory networks
06

Interacting drugs

None identified for MIR4742. In general, anti-miR oligonucleotides (antagomirs) and RNA-based drugs may target microRNAs
07

Biomarkers

MicroRNAs, including MIR4742, can potentially serve as biomarkers for disease diagnosis, prognosis, and monitoring, especially as circulating miRNAs in biofluids

Beyond the preview

Go deeper on MicroRNA 4742 (MIR4742).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4742 (MIR4742).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call